. . . . . . . . . "Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use" . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCC0CnI6yMUipkXh7RB8b/9rRnO8+qDR+pJVf//jGV0r2nd7JcvWFkhPN/eLja/pUw/+nvTE24rhKqK/jWxppJLoka+bk57wrYw43DrSbzQWoJc3ImWe3d08jSYt3mh3uOLWKciogBaonJUBohJsqhTmOULevIPONTZOMzeOJTWwQIDAQAB" . "Faw6TOn8LOES/hlXXOPeRS7wPrrQjJf8wI2fOqyMon3C0KZai6JugAqvKyMBfgsaIgZ2BkQ+MJfNDqssJIDy+5EOMyGdasPBCP9Mp2Kwdnq3O2Nt0NfDvPv5GUiwJyw5/IDNrcqefpYD1JzgmRLxmc8GaW4s74r55J82tqXcMgw=" . . "2021-04-04T21:34:28.183+02:00"^^ . . . . .